Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7:e35671. https://doi.org/10.1371/journal.pone.0035671
Article
CAS
PubMed
PubMed Central
Google Scholar
Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M (2018) Psychosocial burden of localised cutaneous leishmaniasis: a scoping review. BMC Public Health 18:1–12. https://doi.org/10.1186/s12889-018-5260-9
Article
Google Scholar
Brochu C, Wang J, Roy G, Messier N, Wang X-Y, Saravia NG, Ouellette M (2003) Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites. Antimicrob Agents Chemother 47:3073–3079. https://doi.org/10.1128/AAC.47.10.3073-3079.2003
Article
CAS
PubMed
PubMed Central
Google Scholar
Callahan HL, Roberts WL, Rainey PM, Beverley SM (1994) The PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux. Mol Biochem Parasitol 68:145–149. https://doi.org/10.1016/0166-6851(94)00154-5
Article
CAS
PubMed
Google Scholar
Castanys-Munoz E, Perez-Victoria JM, Gamarro F, Castanys S (2008) Characterization of an ABCG like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement. Antimicrob Agents Chemother 52:3573–3579. https://doi.org/10.1128/AAC.00587-08
Article
CAS
PubMed
PubMed Central
Google Scholar
Coelho AC, Beverley SM, Cotrim PC (2003) Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol Biochem Parasitol 130:83–90. https://doi.org/10.1016/S0166-6851(03)00162-2
Article
CAS
PubMed
Google Scholar
Coelho AC, Messier N, Ouellette M, Cotrim PC (2007) Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes. Antimicrob Agents Chemother 51:3030–3032. https://doi.org/10.1128/AAC.00404-07
Article
CAS
PubMed
PubMed Central
Google Scholar
Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111–126. https://doi.org/10.1128/CMR.19.1.111-126.2006
Article
CAS
PubMed
PubMed Central
Google Scholar
Decuypere S, Vanaerschot M, Brunker K, Imamura H, Müller S, Khanal B, Rijal S, Dujardin JC, Coombs GH (2012) Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis 6:e1514. https://doi.org/10.1371/journal.pntd.0001514
Article
PubMed
PubMed Central
Google Scholar
El Fadili K, Messier N, Leprohon P, Roy G, Guimond C, Trudel N, Saravia NG, Papadopoulou B, Legare D, Ouellete M (2005) Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother 49:1988–1993. https://doi.org/10.1128/AAC.49.5.1988-1993.2005
Article
CAS
PubMed
PubMed Central
Google Scholar
Eslami G, Zarchi MV, Moradi A, Hejazi SH, Sohrevardi SM, Vakili M, Khamesipour A (2016) Aquaglyceroporin1 gene expression in antimony resistance and susceptible Leishmania major isolates. J Vector Borne Dis 53:370
CAS
PubMed
Google Scholar
Fekrisoofiabadi M, Fekri M, Moradabadi A, Vahidi R, Khaleghi M, Ram M, Dabiri S (2019) Evaluation of MDR1 and MRPA genes expression in different types of dry cutaneous leishmaniasis. BMC Res Notes 12:803. https://doi.org/10.1186/s13104-019-4784-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Firooz A, Mortazavi H, Khamesipour A, Ghiasi M, Abedini R, Balighi K, Esmaili N, Nassiri-Kashani M, Eskandari SE, Moheballi M, Mir Amin Mohammadi A, Dowlati Y (2020) Old world cutaneous leishmaniasis in Iran: clinical variants and treatments. J Dermatol Treat 32:673–686. https://doi.org/10.1080/09546634.2019.1704214
Article
CAS
Google Scholar
Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006) Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 3:e162. https://doi.org/10.1371/journal.pmed.0030162
Article
CAS
PubMed
PubMed Central
Google Scholar
Haldar AK, Sen P, Roy S (2011) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int 2011:571242. https://doi.org/10.4061/2011/571242
Article
PubMed
PubMed Central
Google Scholar
Jabini R, Jaafari M, Hasani FV, Ghazizadeh F, Khamesipour A, Karimi G (2015) Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice. Drug Res 65:119–124. https://doi.org/10.1055/s-0034-1370914
Article
CAS
Google Scholar
Kakooei Z, Hajjaran H, Akhoundi B, Charehdar S, Elikaee S, Shafeghat Z, Hassanpour H, Satvat MT, Kazemi-Rad E, Mohebali M (2020) Treatment failure in cutaneous leishmaniasis patients referred to the School of Public Health, Tehran University of Medical Sciences during 2008–2017. J Arthropod Borne Dis 14:363–375. https://doi.org/10.18502/jad.v14i4.5274
Article
PubMed
PubMed Central
Google Scholar
Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Saffari M, Raoofian R, Hajjaran H, Hadighi R, Khamesipour A, Rezaie S, Abedkhpjasteh H, Heidari M (2013) Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol 135:344–349. https://doi.org/10.1016/j.exppara.2013.07.018
Article
CAS
PubMed
Google Scholar
Légaré D, Richard D, Mukhopadhyay R, Stierhof Y-D, Rosen BP, Haimeur A, Papadopoulou B, Ouellette M (2001) The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem 276:26301–26307. https://doi.org/10.1074/jbc.M102351200
Article
PubMed
Google Scholar
Leprohon P, Fernandez-Prada C, Gazanion É, Monte-Neto R, Ouellette M (2015) Drug resistance analysis by next generation sequencing in Leishmania. Int J Parasitol Drugs Drug Resist 5:26–35. https://doi.org/10.1016/j.ijpddr.2014.09.005
Article
PubMed
Google Scholar
Leprohon P, Légaré D, Girard I, Papadopoulou B, Ouellette M (2006) Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryot cell 5:1713–1725. https://doi.org/10.1128/EC.00152-06
Article
CAS
PubMed
PubMed Central
Google Scholar
Leprohon P, Légaré D, Ouellette M (2009) Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials. Antimicrob Agents Chemother 53:2646–2649. https://doi.org/10.1128/AAC.01474-08
Article
CAS
PubMed
PubMed Central
Google Scholar
Manzano JI, García-Hernández R, Castanys S, Gamarro F (2013) A new ABC half-transporter in Leishmania major is involved in resistance to antimony. Antimicrob Agents Chemother 57:3719–3730. https://doi.org/10.1128/AAC.00211-13
Article
CAS
PubMed
PubMed Central
Google Scholar
Manzano JI, Lecerf-Schmidt F, Lespinasse MA, Di Pietro A, Castanys S, Boumendjel A, Gamarro F (2014) Identification of specific reversal agents for Leishmania ABCI4-mediated antimony resistance by flavonoid and trolox derivatives screening. J Antimicrob Agents 69:664–672. https://doi.org/10.1093/jac/dkt407
Article
CAS
Google Scholar
Martínez DY, Llanos-Cuentas A, Dujardin JC, Polman K, Adaui V, Boelaert M, Verdonck K (2020) A case–control study on the association between intestinal helminth infections and treatment failure in patients with cutaneous leishmaniasis. Open Forum Infect Dis 7:ofaa155. https://doi.org/10.1093/ofid/ofaa155
Article
CAS
PubMed
PubMed Central
Google Scholar
Mukherjee A, Padmanabhan PK, Singh S, Roy G, Girard I, Chatterjee M, Ouellette M, Madhubala R (2007) Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 59:204–211. https://doi.org/10.1093/jac/dkl494
Article
CAS
PubMed
Google Scholar
Norouzinezhad F, Ghaffari F, Norouzinejad A, Kaveh F, Gouya MM (2016) Cutaneous leishmaniasis in Iran: results from an epidemiological study in urban and rural provinces. Asian Pac J Trop Biomed 6:614–619. https://doi.org/10.1016/j.apjtb.2016.05.005
Article
Google Scholar
Ouellette M, Legare D, Haimeur A, Grondin K, Roy G, Brochu C, Papadopoulou B (1998) ABC transporters in Leishmania and their role in drug resistance. Drug Resist Updat 1:43–48. https://doi.org/10.1016/S1368-7646(98)80213-6Get
Article
CAS
PubMed
Google Scholar
Perea A, Manzano JI, Castanys S, Gamarro F (2016) The LABCG2 transporter from the protozoan parasite Leishmania is involved in antimony resistance. Antimicrob Agents Chemother 60:3489–3496. https://doi.org/10.1128/AAC.02813-15
Article
CAS
PubMed
PubMed Central
Google Scholar
Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, López-Vélez R, García-Hernández R, Pountain AW, Mwenechanya R, Papadopoulou B (2017) Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis 11:e0006052. https://doi.org/10.1371/journal.pntd.0006052
Article
CAS
PubMed
PubMed Central
Google Scholar
Purkait B, Kumar A, Nandi N, Sardar AH, Das S, Kumar S, De T, Singh D, Das P (2012) Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother 56:1031–1041. https://doi.org/10.1128/AAC.00030-11
Article
CAS
PubMed
PubMed Central
Google Scholar
Rastrojo A, García-Hernández R, Vargas P, Camacho E, Corvo L, Imamura H, Dujardin JC, Castanys S, Aguado B, Gamarro F, Requena JM (2018) Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs. Int J Parasitol Drugs Drug Resist 8:246–264. https://doi.org/10.1016/j.ijpddr.2018.04.002
Article
PubMed
PubMed Central
Google Scholar
Rugani JN, Gontijo CMF, Frézard F, Soares RP, Monte-Neto RLD (2019) Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake. Mem Inst Oswaldo Cruz 114:e190111. https://doi.org/10.1590/0074-02760190111
Article
CAS
PubMed
PubMed Central
Google Scholar
Somee R, Eslami G, Vakili M (2021) Mitogen-activated protein kinase and aquaglyceroporin gene expression in treatment failure Leishmania major. Acta Parasitol. https://doi.org/10.1007/s11686-021-00463-8
Article
PubMed
Google Scholar
Vanaerschot M, Dumetz F, Roy S, Ponte-Sucre A, Arevalo J, Dujardin JC (2014) Treatment failure in leishmaniasis: drug-resistance or another (epi-). phenotype? Expert Rev Anti Infect Ther 12:937–946. https://doi.org/10.1586/14787210.2014.916614
Article
CAS
PubMed
Google Scholar
WHO (2020) Leishmaniasis: status of endemicity of cutaneous leishmaniasis (2020). https://www.who.int/data/gho/data/themes/topics/gho-ntd-leishmaniasis